Trial Outcomes & Findings for A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases. (NCT NCT00728754)

NCT ID: NCT00728754

Last Updated: 2024-08-20

Results Overview

Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

61 participants

Primary outcome timeframe

1 year

Results posted on

2024-08-20

Participant Flow

Up to 120 patients were enrolled across all centers, with enrollment efforts beginning in February 2005. Enrollment period remained open until June 2006. Two participating sites were Universities and four were private practices.

Pre-treatment included a screening visit (enroll those meeting all inclusion criteria), signing informed consent, and pre-surgical data collection.Patients returned for implant placement surgery, followed by temporary prosthesis placement at 2 months.

Participant milestones

Participant milestones
Measure
Osseotite Certain Prevail Implant
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
Osseotite Certain Implant
Patients with dental implant with internal connection and without the lateralized expanded platform design
Implant Placement Surgery
STARTED
29
32
Implant Placement Surgery
COMPLETED
29
32
Implant Placement Surgery
NOT COMPLETED
0
0
Permanent Prosthesis Placement
STARTED
29
32
Permanent Prosthesis Placement
COMPLETED
25
28
Permanent Prosthesis Placement
NOT COMPLETED
4
4
One Year Post Placement Follow-up
STARTED
25
28
One Year Post Placement Follow-up
COMPLETED
24
28
One Year Post Placement Follow-up
NOT COMPLETED
1
0
Two Year Post Placement Follow-up
STARTED
24
28
Two Year Post Placement Follow-up
COMPLETED
24
28
Two Year Post Placement Follow-up
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Osseotite Certain Prevail Implant
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
Osseotite Certain Implant
Patients with dental implant with internal connection and without the lateralized expanded platform design
Permanent Prosthesis Placement
Adverse Event
1
1
Permanent Prosthesis Placement
Lost to Follow-up
3
3
One Year Post Placement Follow-up
Adverse Event
1
0

Baseline Characteristics

A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Osseotite Certain Prevail Implant
n=29 Participants
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
Osseotite Certain Implant
n=32 Participants
Patients with dental implant with internal connection and without the lateralized expanded platform design
Total
n=61 Participants
Total of all reporting groups
Age, Customized
<=18 years
0 participants
n=99 Participants
0 participants
n=107 Participants
0 participants
n=206 Participants
Age, Customized
Between 18 and 65 years
18 participants
n=99 Participants
21 participants
n=107 Participants
39 participants
n=206 Participants
Age, Customized
>=65 years
11 participants
n=99 Participants
11 participants
n=107 Participants
22 participants
n=206 Participants
Sex/Gender, Customized
Female
14 participants
n=99 Participants
15 participants
n=107 Participants
29 participants
n=206 Participants
Sex/Gender, Customized
Male
15 participants
n=99 Participants
17 participants
n=107 Participants
32 participants
n=206 Participants
Region of Enrollment
United States
6 participants
n=99 Participants
8 participants
n=107 Participants
14 participants
n=206 Participants
Region of Enrollment
Italy
15 participants
n=99 Participants
15 participants
n=107 Participants
30 participants
n=206 Participants
Region of Enrollment
Sweden
5 participants
n=99 Participants
4 participants
n=107 Participants
9 participants
n=206 Participants
Region of Enrollment
Australia
3 participants
n=99 Participants
5 participants
n=107 Participants
8 participants
n=206 Participants

PRIMARY outcome

Timeframe: 1 year

Population: population analyzed was all patients receiving implants enrolled in the study, those reported here actually represent the number of implants being followed at the 12 month follow-up time point (time of analysis).

Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.

Outcome measures

Outcome measures
Measure
Osseotite Certain Prevail Implant
n=65 implants
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
Osseotite Certain Implant
n=68 implants
Patients with dental implant with internal connection and without the lateralized expanded platform design
Crestal Bone Regression (Amount of Bone Measured) Around Each Implant Unit
-0.7440 millimeters
Standard Error 0.1881
-0.8445 millimeters
Standard Error 0.1439

SECONDARY outcome

Timeframe: four years

Outcome measures

Outcome data not reported

Adverse Events

Osseotite Certain Prevail Implant

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Osseotite Certain Implant

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Osseotite Certain Prevail Implant
n=29 participants at risk
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
Osseotite Certain Implant
n=32 participants at risk
Patients with dental implant with internal connection and without the lateralized expanded platform design
Surgical and medical procedures
Loss of integration of implant
17.2%
5/29 • Number of events 5 • Adverse events are collected and reported from day 1 of the study to present, 4 years of study duration to date.
Adverse event data is collected by patient questioning and visual examination of patient's mouth each study event visit.
15.6%
5/32 • Number of events 5 • Adverse events are collected and reported from day 1 of the study to present, 4 years of study duration to date.
Adverse event data is collected by patient questioning and visual examination of patient's mouth each study event visit.

Additional Information

Clinical Research Manager

Biomet 3i LLC

Phone: 5617766722

Results disclosure agreements

  • Principal investigator is a sponsor employee PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
  • Publication restrictions are in place

Restriction type: OTHER